Abstract
Arachidonic acid is metabolized to prostaglandin, lipoxygenase products, and products of the microsomal cytochrome P-450 enzymes of the kidney. The distribution of the metabolizing enzymes and their regulation and pharmacologic manipulation are reviewed. The mechanisms of release of arachidonic acid from membrane lipids through a surface-mediated receptor mechanism are also discussed. The localization of the various enzymes and product formation may have profound effects on glomerular filtration, renal blood flow, and electrolyte excretion. Therefore, an understanding of the potential sites of inhibition of the nonsteroidal anti-inflammatory drugs is important in assessing their effects on renal function.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Animals
-
Arachidonic Acid
-
Arachidonic Acids / metabolism*
-
Binding Sites
-
Cyclooxygenase Inhibitors
-
Cytochrome P-450 Enzyme System / metabolism
-
Dinoprostone
-
Eicosanoic Acids / metabolism
-
Epoprostenol / metabolism
-
Humans
-
Kidney / drug effects
-
Kidney / enzymology
-
Kidney / metabolism*
-
Lipoxygenase / metabolism
-
Oxidation-Reduction
-
Prostaglandin Endoperoxides, Synthetic / metabolism
-
Prostaglandin H2
-
Prostaglandin-Endoperoxide Synthases / metabolism
-
Prostaglandins / biosynthesis
-
Prostaglandins E / metabolism
-
Prostaglandins H / metabolism
-
Substrate Specificity
-
Thromboxanes / biosynthesis
Substances
-
Arachidonic Acids
-
Cyclooxygenase Inhibitors
-
Eicosanoic Acids
-
Prostaglandin Endoperoxides, Synthetic
-
Prostaglandins
-
Prostaglandins E
-
Prostaglandins H
-
Thromboxanes
-
Arachidonic Acid
-
Prostaglandin H2
-
Cytochrome P-450 Enzyme System
-
Epoprostenol
-
Lipoxygenase
-
Prostaglandin-Endoperoxide Synthases
-
Dinoprostone